Translate Bio Announces FDA Clearance to Proceed with a Single-ascending Dose (SAD) Phase 1/2 Clinical Trial for Ornithine Transcarbamylase (OTC) Deficiency

NEXT STORY
Depyrogenated Sterile Empty Vials Market to hit $8 billion by 2025: Global Market Insights, Inc.
PREV STORY
Teleflex Announces Expanded Nationwide Coverage for the UroLift System for Patients with Enlarged Prostate
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Kura Oncology Reports First Quarter 2018 Financial Results and Provides Corporate Update

– Registration-directed trial of tipifarnib in HRAS mutant head and neck squamous cell carcinomas ...

author_avatar
NASDAQ Market News

Communique from EGM in Oncology Venture A/S

  Company Announcement Communique from EGM in Oncology Venture A/S Hoersholm, Denmark, December 18, ...

author_avatar
NASDAQ Market News

BeiGene Reports Second Quarter 2017 Financial Results

CAMBRIDGE, Mass. and BEIJING, China, Aug. 09, 2017 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ:BGNE), ...

author_avatar
NASDAQ Market News